Humira

Sanofi Drug Beats AbbVie's Blockbuster Humira in Clinical Trial
Sanofi and Regeneron Pharmaceuticals Inc. said an experimental rheumatoid arthritis therapy helped patients more than AbbVie Inc.'s Humira in a late-stage trial. The treatment, sarilumab, improved signs and symptoms of rheumatoid arthritis more than ... [...]
6
Like
Save
Sanofi and Regeneron's would-be blockbuster tops Humira in arthritis
The treatment, sarilumab, is an antibody targeting the inflammation-related protein interleukin-6 to treat autoimmune disease. In a late-stage trial enrolling 369 patients, the therapy beat out Humira in clearing up rheumatoid arthritis symptoms after ... [...]
2
Like
Save
Sanofi Drug Beats AbbVie's Blockbuster Humira in Human Trial
Sanofi and Regeneron Pharmaceuticals Inc. said an experimental rheumatoid arthritis therapy helped patients more than AbbVie Inc.'s Humira in a late-stage trial. The treatment, sarilumab, improved signs and symptoms of rheumatoid arthritis more than ... [...]
2
Like
Save